Ophthalmology, Retina Specialist · North Miami Beach, FL
NPI
1235672585
Since 2016
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
184 NE 168th St
North Miami Beach, FL, 33162
Phone (305) 655-0411
Groups this clinician bills Medicare through
Medicare paid, 2024
$349K
3,143 services
Medicare patients, 2024
290
Average age 75
Drug cost, 2024
$2.1M
2,046 prescriptions
Company payments, 2025
$92.37
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sulaiman Alhumaid was code 92134 (computerized ophthalmic imaging), 758 times for 265 patients. In total Sulaiman Alhumaid billed 3,143 services in 23 codes, and Medicare paid $349K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92134 Computerized Ophthalmic Imaging | Office | 758 | 265 | $32.64 | $25K |
| 92012 Ophthalmological E&M | Office | 508 | 138 | $73.30 | $37K |
| 67028 Intravitreal Injection | Office | 483 | 84 | $106.46 | $51K |
| 92014 Ophthalmological E&M | Office | 319 | 216 | $89.54 | $29K |
| J7999 Compounded drug, not otherwise classified | Office | 263 | 53 | $60.23 | $16K |
| J0178 Injection, aflibercept, 1 mg | Office | 222 | 28 | $662.86 | $147K |
| 92250 Angiography | Office | 174 | 126 | $29.04 | $5,053 |
| J9999 Not otherwise classified, antineoplastic drugs | Office | 68 | 33 | $62.72 | $4,265 |
| 92004 Ophthalmological E&M | Office | 43 | 43 | $94.02 | $4,043 |
| J9035 Injection, bevacizumab, 10 mg | Office | 30 | 23 | $58.29 | $1,749 |
| 92235 Angiography | Office | 27 | 26 | $135.54 | $3,660 |
By year: 2022 $492K for 2,690 services; 2023 $326K for 2,868 services; 2024 $349K for 3,143 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sulaiman Alhumaid prescribed most often to Medicare patients was Eylea (Aflibercept), with 874 prescriptions and refills. In total Sulaiman Alhumaid wrote 2,046 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 874 | 885 | 154 | $1.9M |
| Prednisolone Acetate Generic | 402 | 635 | 140 | $20K |
| Ketorolac Tromethamine Generic | 368 | 495 | 107 | $9,799 |
| Lucentis Ranibizumab | 58 | 58 | Under 11 | $110K |
| Ofloxacin Generic | 51 | 58 | 37 | $820 |
| Latanoprost Generic | 40 | 70 | 19 | $276 |
| Ozurdex Dexamethasone | 29 | 86 | 11 | $48K |
| Timolol Maleate Generic | 28 | 45 | 14 | $123 |
| Lumigan Bimatoprost | 26 | 46 | 22 | $9,521 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 24 | 50 | 11 | $241 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 20 | 28 | Under 11 | $1,822 |
| Brimonidine Tartrate Generic | 18 | 33 | Under 11 | $1,079 |
| Diclofenac Sodium Generic | 13 | 22 | Under 11 | $92.94 |
| Simbrinza Brinzolamide/Brimonidine Tart | 11 | 16 | Under 11 | $2,215 |
| Prolensa Bromfenac Sodium | 11 | 13 | Under 11 | $4,876 |
Brand drugs: 1,499 claims; generic drugs: 547 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sulaiman Alhumaid $92.37 ($92.37 in general payments such as food, travel and fees) from 2 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $63.28.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.